Fibran Plus 250 mg/250 mg Tablet
By Fibran Plus
Rx
10 Tablet in a Strip

Composition
Tranexamic Acid(250mg) + Ethamsylate(250mg)

Manufacturer - Obsurge Biotech Ltd
101-102 Aditya Tower, District Centre, Laxmi Nagar, Delhi : 110092, India

Expires on or after
September, 2025

liver
Fibran Plus 250 mg/250 mg Tablet is considered safe for patients with liver disease based on available data. It appears that adjusting the dosage of Fibran Plus 250 mg/250 mg Tablet may not be necessary for individuals with liver issues. It is advisable to consult with your doctor regarding the use of this medication to ensure proper guidance and monitoring.

kidney
Fibran Plus 250 mg/250 mg Tablet needs caution in kidney disease. Dosage adjustment may be necessary. Consult your doctor regarding kidney concerns.

alcohol
Fibran Plus 250 mg/250 mg Tablet can lead to increased drowsiness when used with alcohol.

driving
You should not experience any driving impairment while taking Fibran Plus 250 mg/250 mg Tablet.

pregnancy
It is better to consult your doctor before using Fibran Plus 250 mg/250 mg Tablet during pregnancy.

breastfeeding
It is better to consult your doctor before using Fibran Plus 250 mg/250 mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | BLOOD RELATED |
Action Class | - |
₹164.75
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 18-Nov-2024